QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

HTFL

QT81Heartflow, Inc. Common Stock
NASDAQ·Healthcare·Medical - Healthcare Information Services·USA
Latest market price
33.64
+0.80+2.44%
OverviewShort InterestFilings
HTFLQT81Heartflow, Inc. Common Stock·NASDAQ
OverviewShort InterestFilings
33.64+2.44%
TA
Loading chart...
Screen all →
GEHC+0.72%$61.59VEEV-1.00%$153.30BTSG+2.82%$66.25TEM+4.20%$50.84HQY-1.30%$85.21HNGE+3.55%$69.42TXG+8.19%$34.76DOCS+0.05%$20.46
Snapshot
Index-P/E-EPS (ttm)
-0.88
Insider Own13.90%
Shs Outstand86.24M
Perf Week9.68%
Market Cap2.83BForward P/E-EPS next Y-0.26Insider Trans-4.49%Shs Float-Perf Month26.47%
Enterprise Value2.84BPEG-EPS next Q-0.14Inst Own-Short Float-Perf Quarter29.93%
Income-26055769.00P/S14.80EPS this Y44.16%Inst Trans-Short Ratio-Perf Half Y27.09%
Sales191.42MP/B42.36EPS next Y46.22%ROA-32.51%Short Interest-Perf YTD15.40%
Book/sh3.32P/C-EPS next 5Y-ROE830.46%52W High-Perf Year-
Cash/sh1.83P/FCF-EPS past 3/5Y-ROIC-21.94%52W Low-Perf 3Y-
Dividend Est.-EV/EBITDA-30.56Sales past 3/5Y-Gross Margin78.06%Volatility4.55% 4.50%Perf 5Y-
Dividend TTM-EV/Sales14.83EPS Y/Y TTM-31.37%Oper. Margin-35.83%ATR (14)2.01Perf 10Y-
Dividend Ex-Date-Quick Ratio5.57Sales Y/Y TTM51.59%Profit Margin-58.42%RSI (14)63.50Recom2.17
Dividend Gr. 3/5Y-Current Ratio5.57EPS Q/Q-33.33%SMA2010.80%Beta1.90Target Price37.00
Payout0.00%Debt/Eq0.09Sales Q/Q43.24%SMA5012.50%Rel Volume1.53Prev Close32.84
Employees626LT Debt/Eq0.05EarningsSep 18SMA20012.04%Avg Volume1.18MPrice33.64
IPO DateAug 07, 2025Option/ShortYes / YesEPS/Sales Surpr.14.73% 6.00%Net Debt/EBITDA-0.07Volume1,805,306Change2.44%
Analyst Ratings
DateActionAnalystRatingTarget
May-15-26ReiteratedWells FargoOverweight$38 → $37
May-15-26ReiteratedCanaccord GenuityBuy$35 → $37
Jan-28-26InitiatedWells FargoOverweight$38
Sep-02-25InitiatedMorgan StanleyEqual Weight$35
Sep-02-25InitiatedCanaccordBuy$35
Sep-02-25InitiatedStifelBuy$35
Sep-02-25InitiatedPiper SandlerOverweight$38
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
Total Revenue191176126
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A424131
Gross Profit14913594
Selling, General and Administrative Excl. Other145134112
Research and Development736544
Other Operating Expense
000
Operating Income-69-64-61
Interest Expense101523
Unusual Expense
———
Non-Operating Income (Expense)333812
Net Income Before Taxes-112-117-96
Income Taxes000
Consolidated Net Income-111-117-96
Net Income From Continuing Operations-111-117-96
Net Income-111-117-96
EPS (Recurring)-0.88-0.32-1.53
EPS (Basic, Before Extraordinaries)-0.88-0.32-1.53
EPS (Diluted)-0.88-0.32-1.53
EBITDA-92-93-65
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio64.9961.12—
Gross Margin78.0176.7074.60
Operating Margin-36.13-36.36-48.41
Net Margin-58.12-66.48-76.19
Shares Outstanding36936963
Market Capitalization12,41310,756—
Operating Lease Expense
———
Insider Trading Volume
$35.24$32.47$29.69$26.91$24.14● Close Price0.00M15.27M30.55M45.82M61.09MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Rogers CampbellChief Medical OfficerJun 15 '26Option Exercise2.2220,00044,40088,731Jun 17 12:00 AM
Farquhar John C.M.Chief Executive OfficerJun 10 '26Sale28.5022,562643,017496,835Jun 12 12:00 AM
Rogers CampbellChief Medical OfficerMay 18 '26Option Exercise19.0018,438350,322101,410May 20 12:00 AM
Rogers CampbellChief Medical OfficerMay 18 '26Sale28.349,219261,26678,731May 20 12:00 AM
Farquhar John C.M.Chief Executive OfficerMay 11 '26Sale29.1222,562657,005519,397May 13 12:00 AM
Bain Capital Life Sciences Investors, LLC10% OwnerApr 30 '26Sale29.23948,75727,733,6448,448,158Apr 30 12:00 AM
Bain Capital Life Sciences Investors, LLC10% OwnerApr 29 '26Sale29.37797,13323,411,7969,396,915Apr 30 12:00 AM
Bain Capital Life Sciences Investors, LLC10% OwnerApr 28 '26Sale30.51254,1107,752,89610,194,048Apr 30 12:00 AM
Farquhar John C.M.Chief Executive OfficerApr 10 '26Sale26.7222,562602,857549,163Apr 14 12:00 AM
Rogers CampbellChief Medical OfficerApr 01 '26Option Exercise2.25134,034301,112145,535Apr 03 12:00 AM
Rogers CampbellChief Medical OfficerApr 01 '26Sale24.6464,5331,590,09381,002Apr 03 12:00 AM
Rogers CampbellChief Medical OfficerMar 19 '26Sale25.6964,5331,658,03378,518Mar 23 12:00 AM
Rogers CampbellChief Medical OfficerMar 19 '26Option Exercise2.22134,034297,554189,125Mar 23 12:00 AM
Farquhar John C.M.Chief Executive OfficerMar 18 '26Sale25.009,725243,125571,725Mar 20 12:00 AM
BARABE TIMOTHY CDirectorMar 11 '26Option Exercise2.2217,33438,482179,521Mar 12 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR